Effect of GLP-1 receptor agonists on body composition
{{output}}
Purpose of review: Obesity is present in up to 85% of individuals with type 2 diabetes mellitus (T2DM) and poses a major therapeutic challenge. Glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed for T2DM, a... ...
